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Conc/usiona: 1. Women with AMI are less often treated with thrombolytic 
agents compared with male patients. ,?. Major reasons: women wore nearly 
one decade older and arrived later to the CCU after onset of symptoms. 3. De- 
spite the higher age women showed an equal frequency of contraindications 
and no difference in the diagnostic accuracy of the ECG upon admission. 4. 
After accounting for other dilfomnces, female sex was independently asso- 
dated with a lower LR. This is presumably caused by an underestimation f
the probability of AMI or the benefits of thrombolytic therapy in women by 
physicians. 
~ D o s s  the Presence or Absence of  Pain at Chest 
Initiation of  Thrombolysis In Acute Myocerdlal 
Infaretion Affect OUtcome? 
David A. Vorchhaimer, Lawrence Bamch, Mardck L Kukin, Karan S. Pisper, 
Chdstopher B. G~,  Edc J. Topoi, Robert M. Califf on behalf of the 
GUSTO-I Investigators. Mount Sinai Medioaf Center, New York, IVY; Duke 
Coordinating Center, Durham, NC 
Dudng acute myocardial infarction (AMI) chest pain may resolve sponta- 
neously or following nitrates or opiates. When symptoms resolve, clinicians 
may avoid thrembolysts. To determine outcomes in patients (pts) who present 
with ongoing electrocardiographic signs of AMI, but CP free, North American 
pts enrolled in the GUSTO-I study wore divided according to presence or 
absence of CP at onset of thmmbelysis. Pain-free pts were older (62,8 vs. 
60.3 years), lighter weight (80.2 vs, 81.6 kg), more often female (32% vs. 
26%), hypertensive (46°/,, vs. 41%), with pdor MI (21% vs. 16°/,); all p < 
0,001.incidence of diabetes was comparable (17% vs. 16%, p = NS). 
Event Pain-Present Pain-Free P value 
(n = 22,426) (n - 1,316) 
Confirmed MI 21932 (98%) 1210 (92%) <0.001 
In-hospitaldeath 1016 (5%) 70 (5%) 0.181 
30 day mortality 1089 (5%) 75 (6%) 0.157 
Reinfarctlen 864 (4%) 59 (4%) 0.248 
Shock 1171 (5%) 65 (5%) 0.659 
CHF/Pulm Edema 3844 (17%) 208 (16%) 0.215 
Stroke 321 (1.4%) 34 (2.6%) 0.001 
Pain-free pts had similar outcomes compared with Path-present; he higher 
stroke incidence is likely attributable to differences in baseline variables. 
Thus, absence of ongoing CP should not preclude lytic administration i pts 
with electrocardiographic evidence of AMI. 
~ Paromedic Diagnosis Myoc~d~!  ECG ol4 
infarction With Direct Admiss ion to Coronary 
Care Results in Reduction in Delay to 
Thrombolysls  
Michael W. Mittar-Craig, Alice V. Joy, Margaret B. A~icz ,  
Roland Furber, Barry Thomas 1 Derbyshire Royal Infirmary,, Derby, United 
Kingdom; 1 Derbyshire Ambulance Service, Derby, United Kingdom 
Aim:To reduce thrombelytic trea~nent delay after myocardial infarction (MI). 
Methods: A prospective study was carded out in which paramedics wore 
trained to record and interpret a standard 12-lead ECG when called to 
suspected MI patients. Dudng the initial training phase (Ph I), ECGs wore 
recorded and patients wore taken to the hospital Emergency Department 
(ED) with subsequent ransfer to the Corenary Care Unit (CCU) for throrn- 
belytic therapy, where appropriate, after assessment by casualty and ad- 
mitting medical staff. Phase II (Ph II) commenced when satisfactory ECG 
recording and interpretative skills had been achieved by paramedics. Dudng 
Ph II, patients with ECG evidence of acute MI or Ischeemia were admitted 
directly to CCU by paramedics using a radio link with CCU. All other patients 
wore taken to the ED in the usual way. Threugheut the study, paramedic 
ECGs wore scored for technical quality and accuracy of interpretation by a 
cardiologist. 
Results: Average accuracy of ECG diagnosis by the paramedics was 
87.5,='0 in Ph I and 92% in Ph II. In Ph i, 123 patients were admitted to CCU 
via the ED, of whom 63 (51"/o) had confirmed MI. In Ph II, 124 patients wore 
admitted irectly to CCU, and MI was confirmed in 71 (57%). One patient In 
Ph II, whose initial paramedic ECG was normal, was taken to the ED where 
MI was subsequently dingnocad. None of the remaining 38 Ph II patients 
taken to the ED with negative ECG sustained MI. 
Mean delay times (minutes) for patients who received thrombolytic therapy 
are shown below. 
Call-site On site 81te.hosp Door-needle Total time 
Phase I 10 30 17 97 154 
Phase II 9 (NS) 31 (NS) 16 (NS) 37 = 93" 
Phase I v Phase II *p < 0.001 (Mann-Wh~ey U test) 
Conclusion: Ao~urate and early diagnosis of MI can be achieved with a 
trained paramedic service, resulting kl == sc~.'stantial reduction in thrombolysis 
delay times. 
~ Early Acednhlbit ion in Patlente With Q- and 
Non-Q Wave Acute Anterior Myocardial Infarction 
Claudio Borghi, Ettore Ambmsioni, Bruno Magnani, for the SMILE 
Investigators. University of Bologna-italy 
The early treatment with the ace-inhibitor zofenopd! has resuff'~:l beneficial in 
patients with acute ML The role of infarct location on mortality and prevalence 
of severe CHF has been evaluated in the SMILE population subdivided in 2 
groups identified by the presence or absence of Q waves in the baseline EKG 
evaluation. The 2 groups of patients were comparable at baseline whereas 
the event rate was greater in patients with Q-wave MI. Zofanopril lmatment 
reduced significantly the 6-woak prevalence of major CV everCs (Death + 
severe CHF) only in patients with Q wave MI. One year mortality was signifi- 
cantly reduced in patients with Q-wave MI by Veatmant with zofenopdl (RR 
40%; 95% C.I, 13-58). No effect on long-term mortality has been observed 
in patients with non-Q wave MI. 
G-week 1 -year 
%Mort;dity %Death + CHF %Moffality 
Plac Zof Plec Znt Plac Zof 
Q w'a~e MI (n = 1270) 7.s 6.0 9.1 6.3" 18.6 12.1" 
Non-Q wave (n = 251 ) 1.0 0.7 1.5 0.9 14.0 14.1 
"p < 0.005 vs Placebo 
We conclude that the benefit of early acs-infiibition can be strongly is 
enhanced in patients with Q wave MI. 
~ Plasma Plasmlnogen Activator-1 Level (PAF1 L) 
Increase After Thrembolyt lc Therapy. A 
Randomized-Controlled Study W~:h 
Stmptoklnase (SK) and Recembina~: T~;ue-Type 
Plasminogen Activater (rt-PA). 
Fransk Paganelli 1, Made C. Alessi 2 Jean M. Malxent 1,/Main Saadjjian 1 
Samuel Levy I , Irene Juhen-Vague 2.1 Division of Cardiology, School of 
Medicine, Marseille, France: 2 Deparfment of Hae~ School of 
Medicine, Marseille, France 
PAl-1 plays an important role in regulating fibrinolysF,;. F )q~fiments in animals 
have shown that modulation of PAl-1 activity in plasma influence thrombosis. 
, It have been previously shown that PAl-1 L increase after rtPA injection in 
vivo. Whether or not this rebound is tPA specir¢ is not known. Reasons 
for resistance to thmmbelysis may be antifibdnolytic rebound phenomenon 
after thrombolylJc therapy (TI'). Our aim was to compare volution of PAl-1 L 
after rtPA and SK administration. PAl-1 activity and antigen were measured 
sedally (0, 3, 6, 12, 18, 24, 48 hours) in 53 cons~ patients (tots) 
with acute myocardial infarction (AMI). After randomization, 28 pts received 
inVevanously SK (1.5 Million Units) and 25 pts rt-PA aocom3ng to GUSTO. 
Hours PAl-1 ant~en (ng/rnl) PAl-1 activ~ (U//ml) 
rt-PA SK ft-PA SK 
0 (before TI") 444-8 38<-7 194-3 154-3 
.,I ~14 484-8 284-3 174-3 
6 574-7 854-7 234.2 30<-4 
12 44~-5 1;22:1:12 184-2 354-4 
18 434-4 984-10 184-2 384-4 
24 404-4 594-9 164-1 254-3 
48 404-7 404-1 184-3 144-2 
PAl-1 L are markedly increased after SK or rt-PA in AMI. The peak of 
PAl-1 L is higher and occurs later with SK than with rt-PA. These results 
could explain partially slower activity of SK to open occluded a~ery with SK 
compan~l to tlPA. Supported by French Heart Society 
~ Pre-Hospitat In the Second Eleatrecerdlogram 
National Registry of  Myocerdlal Infarction 
(NRMI-2) 
John G. Canto, William J. Rogers, Laura J. Bowrcy, William J. French, 
Douglas J. Pearce, for the NRMI-2 Invas~gators. University of Alabama 
Medical Canter, Birmingham, AL 
The prehospltal electrocardiogram (PH-ECG) has been proposed as a 
means for rapidly identifying patients wkh acute myocardial infarction (AMI) 
who might be eligible for repedusion interventions. Inorder to ascertain char- 
actedstics and outcomes of AMI patients having PH-ECG's, data from the 
ongoing NRMI-2 wore analyzed. 
~E 
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Pre-hospital ECG's were obtained in 2,011 (6.3%) of 31,939 NRMI-2 pa- 
tients who presented to the hospital within 12 hours of an AMI from 6/94 to 
7/95. Transfer or self-transport patients were excluded from this study. Me- 
dian t~me from AMI symptoms onset until hospital ardval was longer among 
those Vested with PH-ECG (2.8 hm vs 1.7 hrs, p < 0.001). However, once 
in the hospital, the PH-ECG treated group conferred a shorter median time 
to the initiation of reperfosion therapy with either thrombelysis (31 min vs 40 
rain, p < 0.001) or pdmory angioptasty (87 rain vs 117 rain, p < 0.001). 
The PH-ECG group was more I~ely to receive thrombelytic therapy (45% 
vs 38%, p < 0.001) and undergo pdmary angioplasty (18% vs 10%, p < 
0.001). Also, the PH-ECG group was more likely to obtain In-hospitat cardiac 
catheterization (54% vs 39%, p < 0.001), angioplasty (21% vs 15°/o, p < 
0,001) or bypass surgery (10% vs 6%, p < 0.001). Hospital mortality was 
7.9% in the PH-ECG group and 12.2% in those without PH-ECG (Io < 0.001 ). 
Alter adjusting for baseline differences utilizing multivariate analysis, this 
mortality difference remained statistically significant (p = 0.02). 
In NRMI-2, the pre-hespital ECG in diagnosing AMI leads to the wider, 
faster in-hospitat utilization of repertusion strategies, as well as the greater 
use of invesive procedures. These factom may help explain the mortality 
advantage seen in the PH-ECG treated group. 
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~ ABC-Leslon Risk Factor for the Type as 
Occurrence of Early and Late Clinical Events in 
Unstable Patients Following Trenslumlnal 
Coronary Angioplasty (PTCA) 
Jean-Paul R. Herrman, Rein Melkert, Rudiger Simon 1, Patrick W. Serruys, 
for the HELVETICA investigators. ~Medizinische UniversitatskUnik, Kiel, 
Germany and Thoraxcentre, Rotterdam, the Netherlands 
Introduction: This study was performed to investigate the relationship be- 
twesn ABC lesion type (AHA/ACC) and eady and tats adverse clinical events 
(4 and 210 days post-PTCA) such as death, myocardial infarction (MI), bail- 
outs, bypass surgery (CABG) and re-PTCA which hamper esults of PTCA. 
Methods: Study population compdsed 1140 patients, prospectively enmled 
in the HELVETICA study, in which hirudln (Hit) iv or iv + sc was compared to 
heparin (Hap) treatment in unstable patients undergoing PTCA for 163 type 
A, 447 type St, 416 type B2 and 114 type C lesions. In case of muitHesion 
dilatation, the most severe lesion type was considered. 
Results: The table presents eady and late ranked clinical ~vent rate in 
percent per lesion type. P-value is from chi-square test for categodcai ranked 
non-parametric variables. 
E~tdy events Late events 
Hir iv + sc Hir iv Hap Total Hit iv + sc Hit iv Hep Total 
N - 378 381 381 1140 378 381 381 1140 
A (N = 163) 1.8 3.6 4.0 3.1 24.6 32,1 16.0 24.5 
B1 (N- 447) 5.6 5.4 7.7 6.3 32.2 33.6 30.3 32.0 
B2 (N = 416) 6.6 12.0 15.3 11.3 36.5 43.0 38.7 39,4 
C (N - 114) 7.3 8.8 17.9 11.4 26.8 20.4 43,6 33.3 
~value NS NS 0.03 0.00 NS N$ 0.01 0,00 
Conclusion: The overall early and late clinical outcome is significantly 
impaired when lesion severity incmasas. This dstdmental trend in clinical 
outcome related to lesion sevedty is however prevented by the use of hirudin. 
~ Plssma Changes in Flbrinolytic end Coagulation 
Activity After PTCA 
Madhu K. Natarajan, Jerome Teitsl, Herbert I-au, Robert Chisholm, 
Bradley Strauss. St. Michasrs Hospital. Toronto, Canada 
Although ypoflbdnolysis and hypercoagulability may be contributing factors 
to restenosis no single study has comprehensively analysed these changes. 
In a pilot study, plasma fibdnolytio and coagulation activity were sedally 
followed for 3 months in 20 patients with stable angina treated with single 
vessel coronary angloplasty. As shown below, we found an eady transient 
fall in PA:-I, highly significant by one-way ANOVA. 
Notably, PAl-1 values pro-PTCA and at all times beyond 6 hr post-PTCA 
were above the normal limit of 30 IU/ml. Urokinase(uPA) levels showed a 
sustafned, significant increase beginning on day 3, An eady, non-significant 
increase in IPA and shortening of the euglobulifi lysls lime were also seen 
(not shown). Factor VII activity fell from 120 4- 10% pre PTCA to 91 4.11% 
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pest (p < 0,005) and returned to baseline levels by 24 hours. RYe of the 
20 patients required ropeat PTCA for restenosis. This subgroup had higher 
initial PAI-I levels and no dse in uPA activity on sedat measurement. 
Conclusions: Patients with stable angina have elevated PAl-1 levels which 
transiently decrease post PTCA. Elevated PAl-1 activity unopposed by an 
insmase in uPA activity may predispose to mstanosts. Based on these results 
we have initiated a larger study with mandatory repeat angtography at 6 
months. 
~ L a t e  Regression of the Dilated Lesion Alter 
Coronary Angloplasty: A 5 Year Quantitative 
Angiogrephlc Study 
John A. Ormiston, Fiona M. Stewart, Antony H.G. Roche, Bruce Webber, 
Mark W.I. Webster. Green Lane Hospital, Auckland, New Zealand 
Although clinical restenosis is uncommon beyond 6 months following coro- 
nary angioplasty (PTCA), them is little quantitative angiographio information 
on long-term changes at the PTCA site. 
Of 127 consecutive patients (pts) with successful PTCA, follow-up cinean- 
giography was obtained 'early' at 2-13 months (moan 7) in 125 pts and 
'late' at 1.5-7.8 years (mean 4.5) in 82 pts (113 lesions).-'Late' angiography 
was performed in 85%0 of those eligible; pta were excluded for repeat PTCA 
(22), mvasculadzation surgery (4) or death (3). Quantitative angiographic 
measurements (CMS-Medls) are mean 4- SD. 
PTCA Follow-Up 
Before Immediate 'Early' 'Law 
MLO (mm) 0.83 4- 0.42 1.90:1:0.48 1 .P,6 ± 0.54 2.12 :E 0.59 
Oiameler 70.3 <- 14.9 34.0 4-12.1 36.2 4-14.2 29.0 ± 11.7 
Stenosis (%) p < 0.001 p = ns p < 0.001 
Between 'eedy' and 'late' follow-up, the minimum lumen diameter (MLD) 
of 45 lesions improved by morn than 2 SD of repeat measuremanta, nd 9 
detsdorated. No patient with a lesion of < 60% diameter stennsis at 'early' 
anglography had a lesion of > 50% stenosis at 'late' aegiagraphy. 
Regression of lesion eavedty between 6 months and 5 years after PTCA is 
a frequent occurrence. This study sheds light on the matanotio process and 
may influence management of lesions of moderate severity 6 months after 
PTCA, 
~ Acute Gain and Late Loss Relationship After 
Coronary Angioplssty Correlates With Geometric 
Remodeling but Not With Changes In Plaque 
Volume 
Takeshi Kimure, Satushl Kaburegi, Himyoshl Yokoi, Yoshihlsa Nakagawa, 
Masaldyo Nobuyoshl, Gall S. Mintz, Jeifery J. Popmo, Martin B. Leon. 
KiPakyushu, Kokura Memorial Hospital, Japan, Washington Hospital Center, 
Washington DC 
Well-known relationship between acute gain lAG) and late loss (LL) after 
coronary angloplasty has been a priori explained by inflma] hyperplasla In 
mspense to injury. AG and LL relationship was analyzed in a cohort of patients 
enrolled in a prospective study by eadai intravascutsr ultrasound (IVUS) 
(motodznd pullback @ 0.5 turn/sac) and quantitative comnanj angiegraphy 
(QCA) (CAAS II) after balloon angioplasty (BA) and directional coronary 
atheroctomy (DCA). Serial studies (pre, past, and 6 months (mos)) with 
adequate IVUS images were completed in 65 lesions (DCA 28, BA 37) (93%) 
out of 70 eligible lesions. The anatomic slice selected for eadai analysis had 
an axlallocation within the target lesion atthe smallest pre-intervention lumen 
cross.sectional rea. 
